Ryan Haumschild, PharmD, MS, MBA, comments on the use of triplet regimens as the standard of care treatment for patients with multiple myeloma, and Thomas Ollis, MS, RPh, shares a community practice perspective.
Ryan Haumschild, PharmD, MS, MBA
Advertisement
Articles by Ryan Haumschild, PharmD, MS, MBA
Joseph Mikhael, MD, reviews the history of multiple myeloma treatment and comments on the evolution of care.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Single-Dose Oral Antibiotic Zoliflodacin Treats Drug-Resistant Gonorrhea
5
